HEMISPHERX BIOPHARMA INC
10-Q, EX-27, 2000-11-14
DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES
Previous: HEMISPHERX BIOPHARMA INC, 10-Q, 2000-11-14
Next: FIRST DEFIANCE FINANCIAL CORP, 10-Q, 2000-11-14



<TABLE> <S> <C>

<ARTICLE> 5

<S>                           <C>
<PERIOD-TYPE>                 9-MOS
<FISCAL-YEAR-END>             DEC-31-2000
<PERIOD-END>                  SEP-30-2000
<CASH>                          6,899,237
<SECURITIES>                    2,282,103
<RECEIVABLES>                     112,350
<ALLOWANCES>                      (29,525)
<INVENTORY>                             0
<CURRENT-ASSETS>                9,455,674
<PP&E>                          1,213,128
<DEPRECIATION>                   (866,091)
<TOTAL-ASSETS>                 13,543,182
<CURRENT-LIABILITIES>             903,385
<BONDS>                                 0
                   0
                             0
<COMMON>                           29,953
<OTHER-SE>                     12,609,844
<TOTAL-LIABILITY-AND-EQUITY>   13,543,182
<SALES>                                 0
<TOTAL-REVENUES>                1,058,563
<CGS>                                   0
<TOTAL-COSTS>                   7,156,233
<OTHER-EXPENSES>                        0
<LOSS-PROVISION>                        0
<INTEREST-EXPENSE>                      0
<INCOME-PRETAX>                         0
<INCOME-TAX>                            0
<INCOME-CONTINUING>            (6,097,670)
<DISCONTINUED>                          0
<EXTRAORDINARY>                         0
<CHANGES>                               0
<NET-INCOME>                   (6,097,670)
<EPS-BASIC>                        (.21)
<EPS-DILUTED>                        (.21)



</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission